{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:50:54Z","timestamp":1784397054648,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004386","name":"Universiti Malaya","doi-asserted-by":"publisher","award":["DOMRSF-2021\u201301"],"award-info":[{"award-number":["DOMRSF-2021\u201301"]}],"id":[{"id":"10.13039\/501100004386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.nmd.2022.01.006","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T11:17:19Z","timestamp":1642850239000},"page":"255-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3578-3493","authenticated-orcid":false,"given":"Cheng-Yin","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khean-Jin","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Wen","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Devaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0031-7692","authenticated-orcid":false,"given":"Nortina","family":"Shahrizaila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2022.01.006_bib0001","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/jnnp-2019-320314","article-title":"Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment","volume":"90","author":"Lehmann","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nmd.2022.01.006_bib0002","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/WNL.0b013e3181e07d14","article-title":"Distinguishing acute-onset CIDP from fluctuating Guillain-Barr\u00e9 syndrome","volume":"74","author":"Ruts","year":"2010","journal-title":"NeurologyNeurology"},{"key":"10.1016\/j.nmd.2022.01.006_bib0003","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nmd.2022.01.006_bib0004","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1007\/s00415-020-09823-2","article-title":"Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features","volume":"268","author":"Tang","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.nmd.2022.01.006_bib0005","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"NeurologyNeurology"},{"key":"10.1016\/j.nmd.2022.01.006_bib0006","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"NeurologyNeurology"},{"key":"10.1016\/j.nmd.2022.01.006_bib0007","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nmd.2022.01.006_bib0008","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2022.01.006_bib0009","doi-asserted-by":"crossref","DOI":"10.1111\/jns.12455","article-title":"European Academy of Neurology\/ Peripheral Nerve Society Guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force \u2013 second revision","author":"Van den Bergh","year":"2021","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.nmd.2022.01.006_bib0010","first-page":"1","volume":"15","author":"Van den Bergh","year":"2010","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.nmd.2022.01.006_bib0011","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.01.006_bib0012","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nmd.2022.01.006_bib0013","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2011.07.042","article-title":"Serial nerve conduction studies provide insight into the pathophysiology of Guillain-Barr\u00e9 and Fisher syndromes","volume":"309","author":"Shahrizaila","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nmd.2022.01.006_bib0014","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/mus.25029","article-title":"Effects of demographic and physical factors on nerve conduction study values of healthy subjects in a multi-ethnic Asian population","volume":"54","author":"Fong","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.01.006_bib0015","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/brain\/awx124","article-title":"Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy","volume":"140","author":"Delmont","year":"2017","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.nmd.2022.01.006_bib0016","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.nmd.2022.01.006_bib0017","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/jns.12344","article-title":"Clinical factors, diagnostic delay, and residual deficits in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"24","author":"Bunschoten","year":"2019","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.nmd.2022.01.006_bib0018","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/jns.12378","article-title":"Relevance of diagnostic investigations in chronic inflammatory demyelinating polyradiculoneuropathy: data from the Italian CIDP database","volume":"25","author":"Liberatore","year":"2020","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"2","key":"10.1016\/j.nmd.2022.01.006_bib0019","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1468-1331.2009.02802.x","article-title":"A nationwide retrospective analysis on the effect of immune therapies in patients with chronic demyelinating inflammatory polyradiculoneuropathy","volume":"17","author":"Cocito","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"8","key":"10.1016\/j.nmd.2022.01.006_bib0020","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/14737175.2017.1340832","article-title":"Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan","volume":"17","author":"Nobile-Orazio","year":"2017","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.nmd.2022.01.006_bib0021","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/jnnp-2017-316427","article-title":"Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial","volume":"88","author":"Kuwabara","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nmd.2022.01.006_bib0022","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.54.3.615","article-title":"Distal acquired demyelinating symmetric neuropathy","volume":"54","author":"Katz","year":"2000","journal-title":"NeurologyNeurology"},{"key":"10.1016\/j.nmd.2022.01.006_bib0023","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.4103\/0028-3886.273621","article-title":"Severe form of M-protein negative distal acquired demyelinating symmetric neuropathy","volume":"67","author":"Ong","year":"2019","journal-title":"Neurol. India"},{"key":"10.1016\/j.nmd.2022.01.006_bib0024","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/mus.21000","article-title":"Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"38","author":"Harbo","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.01.006_bib0025","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp-2014-309697","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype","volume":"86","author":"Mathey","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nmd.2022.01.006_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.637336","article-title":"A systematic review and meta-analysis of autoantibodies for diagnosis and prognosis in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"15","author":"Guo","year":"2021","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.nmd.2022.01.006_bib0027","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1212\/NXI.0000000000000639","article-title":"Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype","volume":"7","author":"Cortese","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.nmd.2022.01.006_bib0028","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","article-title":"IgG4 anti-neurofascin 155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: clinical significance and diagnostic utility of a conventional assay","volume":"301","author":"Kadoya","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nmd.2022.01.006_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577074","article-title":"Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China","volume":"337","author":"Zhang","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nmd.2022.01.006_bib0030","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nmd.2022.01.006_bib0031","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies","volume":"86","author":"Doppler","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nmd.2022.01.006_bib0032","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jim.2005.08.009","article-title":"IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides","volume":"306","author":"Niwa","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.nmd.2022.01.006_bib0033","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/BOR.0b013e3283412fd4","article-title":"What is IgG4?: a review of the biology of a unique immunoglobulin subtype","volume":"23","author":"Nirula","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.nmd.2022.01.006_bib0034","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/jnnp-2021-326343","article-title":"IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality","volume":"92","author":"Fehmi","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nmd.2022.01.006_bib0035","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3389\/fneur.2018.00997","article-title":"Chronic inflammatory demyelinating polyneuropathy with concurrent membranous nephropathy: an anti-paranode and podocyte protein antibody study and literature survey","volume":"9","author":"Hashimoto","year":"2018","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.nmd.2022.01.006_bib0036","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1002\/mus.26392","article-title":"Neuro-renal syndrome\u201d related to anti-contactin-1 antibodies","volume":"59","author":"Taieb","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.01.006_bib0037","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1017\/cjn.2020.46","article-title":"Chronic inflammatory demyelinating polyneuropathy and concurrent membranous nephropathy","volume":"47","author":"Nazarali","year":"2020","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.nmd.2022.01.006_bib0038","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.clinph.2020.01.013","article-title":"Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins","volume":"131","author":"Kouton","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.nmd.2022.01.006_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.759187","article-title":"Characteristics of anti-contactin1 antibody-associated autoimmune nodopathies with concomitant membranous nephropathy","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.nmd.2022.01.006_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-328X(94)90372-7","article-title":"Identification and characterization of the human cell adhesion molecule contactin","volume":"21","author":"Reid","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nmd.2022.01.006_bib0041","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ki.2012.321","article-title":"Neuronal proteins are novel components of podocyte major processes and their expression in glomerular crescents supports their role in crescent formation","volume":"83","author":"Sistani","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.nmd.2022.01.006_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2021.08.014","article-title":"Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy","author":"Le Quintrec","year":"2021","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.nmd.2022.01.006_bib0043","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1177\/0961203312440346","article-title":"Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide","volume":"21","author":"Jasmin","year":"2012","journal-title":"LupusLupus"},{"key":"10.1016\/j.nmd.2022.01.006_bib0044","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fimmu.2013.00235","article-title":"A temporal model of human IgE and IgG antibody function","volume":"4","author":"Collins","year":"2013","journal-title":"Front. Immunol."}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:12:39Z","timestamp":1760775159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896622000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0960896622000220"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2022.01.006","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2022.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}